Our group aims to study the oncogenic mechanisms cancer cells employ in an unbiased manner, by using sufficiently large scale and relevant biological context to find clinically actionable targets for treatment. We believe that this is attainable by combining single-cell transcriptomics of tumors to well-suited data-analysis and validation experiments.